NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Better Data-Driven Healthcare: The State of Real-World Evidence in Canada, 2020

出版商 IDC 商品編碼 951091
出版日期 內容資訊 英文 11 Pages
改善數據驅動醫學:加拿大RWE(真實世界證據)的現狀(2020年) Better Data-Driven Healthcare: The State of Real-World Evidence in Canada, 2020
出版日期: 2020年07月24日內容資訊: 英文 11 Pages





  • 加拿大政府RWE戰略:背景
    • 定義
      • 主要用法示例
      • 主要用戶
      • 主要問題
    • 美國的背景情況
    • 歐洲隨行隨行
    • 加拿大政府RWE策略/活動
      • RWE在藥品監管決策中
      • RWE在醫療器械法規決策中


  • 當前的RWE:案例研究
    • CanREValue(加拿大癌症藥物的RWE)
      • 以患者為中心的研究策略:加拿大數據平台
    • 主要結論


  • 相關研究
  • 摘要
Product Code: CA45672920

This IDC Perspective outlines the current status of Canada's national strategy to optimize the use of real-world evidence based on real-world data for drugs and medical devices and places it within the international context, focusing on parallel activities in the United States and the EU. Real-world evidence derived from RWD presents a significant opportunity to enhance the evidence generated from randomized controlled trials. However, RWE continues to be viewed by most stakeholders as lower quality and less reliable than randomized controlled trials, which continue to be viewed as generating superior evidence. As a result, there are higher comfort levels for using RWE in relation to economic decision making such as HTA recommendations and conditional outcomes-based contracting than for using RWE as evidence of post-market effectiveness.Processes to create a national framework for use of RWE are still at an early stage. Although Canada has separate framework development processes for pharmaceutical drugs and medical devices, it appears to have similar goals and outlines, although slightly different participant structures."The market would welcome a national framework that provides clear guidance on consistent processes, timing, and methods for use of RWE in health sector regulatory decisions," says Mark Schrutt, IDC Canada's strategic advisor, Innovation and Public Sector Research.

Executive Snapshot

Situation Overview

  • Context of Canada's National Real-World Evidence Strategy
    • Definitions
      • Key Use Cases
      • Key Users
      • Key Challenges
    • American Context
    • European RWD
    • Canadian National RWE Strategy Initiative
      • RWE in Drug Regulatory Decisions
      • RWE in Medical Device Regulatory Decisions

Advice for the Technology Buyer

  • Real-World Evidence in Action: Case Study
    • Canadian Real-World Evidence for Value in Cancer (CanREValue)
      • The Strategy for Patient-Oriented Research: Canadian Data Platform
    • Key Takeaways

Learn More

  • Related Research
  • Synopsis